| Literature DB >> 35604921 |
Jason Wei Jian Ng1, Santha Vaithilingam2, Mahendhiran Nair2, Li-Ann Hwang1, Kamarul Imran Musa3.
Abstract
BACKGROUND: As the vaccination drive against the coronavirus disease (COVID-19) in Malaysia progresses rapidly, the main challenge will gradually shift from procuring and distributing vaccines to ensuring the broadest possible acceptance among all population segments. Therefore, this study used the integrated framework of the health belief model (HBM) and the theory of reasoned action (TRA) to investigate the predictors of intention to receive COVID-19 vaccines in Malaysia.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35604921 PMCID: PMC9126375 DOI: 10.1371/journal.pone.0268926
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Fig 1Demographic of respondents according to vaccination intention.
Descriptive statistics of all variables in the national sample (N = 804).
| Characteristic | Unlikely to be vaccinated | Unsure about vaccination | Likely to be vaccinated | Cronbach’s alpha |
|---|---|---|---|---|
|
|
|
| ||
|
|
|
| ||
|
| 2.82 (1.11) | 3.69 (0.75) | 3.92 (0.70) | 0.772 |
|
| 2.48 (0.97) | 3.33 (0.75) | 3.89 (0.71) | 0.802 |
|
| ||||
| Clinical barrier | 4.02 (1.14) | 3.31 (0.65) | 2.87 (0.81) | 0.836 |
| Access barrier | 3.20 (0.83) | 3.24 (0.81) | 3.15 (0.94) | 0.715 |
| Registration barrier | 2.80 (0.87) | 3.02 (0.91) | 2.41 (1.10) | 0.861 |
| Religion barrier | 3.03 (1.48) | 2.31(0.96) | 1.52 (0.84) | 0.826 |
|
| ||||
| Individual benefits | 2.22 (1.39) | 3.42 (0.78) | 4.09 (0.75) | 0.801 |
| Community benefits | 2.49 (1.25) | 3.59 (0.72) | 4.37 (0.59) | 0.776 |
|
| 1.55 (0.70) | 3.10 (0.74) | 4.39 (0.80) | 0.904 |
|
| 1.88 (0.81) | 3.45 (0.65) | 4.51 (0.57) | 0.943 |
|
| ||||
| Vaccine | 1.82 (1.12) | 3.25 (0.78) | 3.99 (0.76) | 0.912 |
| Information | 2.40 (0.85) | 3.37 (0.75) | 3.82 (0.65) | 0.732 |
|
|
|
| ||
|
| N.A. | |||
| AstraZeneca | 0 (0%) | 18 (14%) | 64 (9.7%) | |
| Moderna | 0 (0%) | 8 (6.2%) | 26 (3.9%) | |
| Pfizer | 6 (40%) | 52 (40%) | 346 (52%) | |
| Sinovac | 2 (13%) | 23 (18%) | 90 (14%) | |
| Any of the above | 7 (47%) | 28 (22%) | 134 (20%) | |
|
| N.A. | |||
| No/Unsure | 14 (93%) | 63 (49%) | 142 (22%) | |
| Yes | 1 (6.7%) | 66 (51%) | 518 (78%) |
Logistic regression model of COVID-19 vaccine intention.
| Logistic | |||
|---|---|---|---|
| Likely | |||
| (Ref: Unlikely & Unsure) | |||
| Characteristic | OR | 95% CI | |
| Age | 1.03 | 1.00, 1.06 | 0.032 |
|
| |||
| Female | — | — | |
| Male | 0.83 | 0.47, 1.46 | 0.5 |
|
| |||
| Secondary or lower | — | — | |
| Diploma | 1.37 | 0.60, 3.14 | 0.5 |
| Tertiary | 1.12 | 0.52, 2.40 | 0.8 |
|
| |||
| Less than RM1,000 | — | — | |
| RM1,000–RM3,999 | 0.49 | 0.20, 1.18 | 0.12 |
| RM4,000-RM6,999 | 0.61 | 0.24, 1.48 | 0.3 |
| RM7,000-RM9,999 | 0.62 | 0.19, 2.01 | 0.4 |
| Above RM10,000 | 0.76 | 0.17, 3.84 | 0.7 |
| Severity | 1.01 | 0.64, 1.58 | >0.9 |
| Susceptibility | 2.14 | 1.38, 3.38 | <0.001 |
| Clinical barriers | 1.08 | 0.66, 1.75 | 0.8 |
| Access barriers | 1.38 | 0.92, 2.09 | 0.13 |
| Registration barriers | 0.91 | 0.66, 1.25 | 0.6 |
| Religion barriers | 0.58 | 0.41, 0.80 | 0.001 |
| Individual benefits | 1.02 | 0.59, 1.71 | >0.9 |
| Community benefits | 1.38 | 0.78, 2.48 | 0.3 |
| Attitude | 2.46 | 1.69, 3.65 | <0.001 |
| Subjective norms | 3.79 | 2.33, 6.35 | <0.001 |
| Trust in vaccine | 1.78 | 1.13, 2.81 | 0.013 |
| Trust in information | 0.81 | 0.48, 1.36 | 0.4 |
|
| |||
| AstraZeneca | — | — | |
| Moderna | 1.55 | 0.39, 6.49 | 0.5 |
| Pfizer | 1.11 | 0.44, 2.76 | 0.8 |
| Sinovac | 0.76 | 0.26, 2.15 | 0.6 |
| Any of the above | 0.96 | 0.34, 2.62 | >0.9 |
|
| |||
| No/Unsure | — | — | |
| Yes | 1.31 | 0.72, 2.36 | 0.4 |
a OR = Odds Ratio.
b CI = Confidence Interval.